Brent Saunders

Entrepreneur, investor and Bitcoin (CRYPTO: BTC) bull Anthony Pompliano has a new SPAC targeting the financial services sector and perhaps a company dealing with cryptocurrency. While the SPAC could target the cryptocurrency space, Pompliano said that's not a definite yes. The SPAC: Pompliano took...

Jim Cramer is no fan of Mylan NV (NASDAQ: MYL) and how it handled the EpiPen controversy. Cramer ranted on Thursday's "Squawk Box" that EpiPen has to be a "much bigger source" of Mylan's profit than the company is letting on and he would like to see the company's...

Allergan plc Ordinary Shares (NYSE: AGN) paid a hefty premium of 159 percent to acquire Vitae Pharmaceuticals Inc (NASDAQ: VTAE) last week, but that figure pales in comparison to the premium attached to its acquisition of Tobira Therapeutics Inc (NASDAQ: TBRA). Allergan will pay $533 million in...

Tobira Therapeutics Inc (NASDAQ: TBRA), a clinical-stage bio-pharmaceutical company that focuses on the development of therapies to treat non-alcoholic steatohepatitis (NASH) and other liver diseases, soared higher by more than 760 percent on Tuesday after the company agreed to sell itself to...

Twitter Inc (NYSE: TWTR) can be an extremely useful and tradable tool for investors, but only if you follow the right people. Here’s a look at 11 biotech and pharmaceutical company CEOs that have the potential for market-moving tweets. 1. Brent Saunders - @brentlsaunders Saunders is...

Allergan plc Ordinary Shares (NYSE: AGN) announced mixed results as the revenue numbers came below the Street estimate. However, the company's adjusted EPS topped by a penny. Its guidance for the full year also disappointed. The company reported GAAP operating loss from continuing operations of $...

The billionaire investor confirmed through his Twitter account that he has acquired a "large position" in Allergan plc Ordinary Shares (NYSE: AGN). Shares of Allergan were trading higher by more than 2.5 percent after Tuesday's opening bell. Icahn also said in a statement is he is...

Pfizer Inc. (NYSE: PFE) announced Wednesday morning it has terminated its merger agreement with Allergan plc (NYSE: AGN) following the U.S. Department of Treasury's tax inversion announcement on Monday. Pfizer noted the decision to terminate the merger agreement was mutual. As part of the...

After months of takeover talks, more consolidation in the healthcare space has come to fruition. On Monday morning, Pfizer Inc. (NYSE: PFE) announced it has purchased Allergan PLC (NYSE: AGN) in a deal valued at about $155 billion, the largest ever in the healthcare sector. The transaction is...

In a report published Wednesday, BMO Capital Markets analyst David Maris discussed key takeaways from a day of meetings with several specialty pharmaceutical companies. Below are some of the highlights of notable presentations. Allergan PLC (NYSE: AGN): The company is planning to work...

Four pharmaceutical companies have been flirting with merger deals. Discussing the confusing courting, Barron’s called them the Bob & Carol & Ted & Alice of pharmaceuticals, referencing the sexy 1969 comedy-drama with the tag line “Consider the Possibilities.” In...

U.S. stocks declined a day after the S&P 500 and Dow indices traded at record-high levels. Investors and traders were likely paying attention to the ten-year Treasury yield which hit 2.5258, the lowest level since late October. The bull market has paused, temporarily at least, until...